Efficacy of a formalin-inactivated vaccine against Streptococcus iniae infection in the farmed grouper Epinephelus coioides by intraperitoneal immunization
•Proposed vaccine induces the upregulation of immune-related genes.•Vaccinated fish showed significant increase of phagocytic activity.•Groupers vaccinated using the tested vaccine had increased serum agglutination titers.•Proposed vaccine provides protective efficacy against S. iniae.•Proposed vacc...
Saved in:
| Published in | Vaccine Vol. 32; no. 51; pp. 7014 - 7020 |
|---|---|
| Main Authors | , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Kidlington
Elsevier Ltd
05.12.2014
Elsevier |
| Subjects | |
| Online Access | Get full text |
| ISSN | 0264-410X 1873-2518 1873-2518 |
| DOI | 10.1016/j.vaccine.2014.08.039 |
Cover
| Abstract | •Proposed vaccine induces the upregulation of immune-related genes.•Vaccinated fish showed significant increase of phagocytic activity.•Groupers vaccinated using the tested vaccine had increased serum agglutination titers.•Proposed vaccine provides protective efficacy against S. iniae.•Proposed vaccine provides safe and long-lasting protection in farmed groupers.
Vaccination is the most effective means of preventing infectious diseases; however, few vaccines are effective against Streptococcus iniae (S. iniae) in grouper. This work presents an efficacious and safe vaccine against S. iniae infections in the grouper Epinephelus coioides. The vaccine candidate was the S. iniae GSI-310 strain. The vaccination was administered by intraperitoneal injection, and consisted of formalin-inactivated antigens combined with an AS-F or ISA763A adjuvant. Peripheral blood samples were collected for RT-qPCR and phagocytosis and agglutination assays. Our results indicated that immunoglobulin M (igm) was maximally expressed in the two vaccinated groups at 3 months post-secondary vaccination (PSV). A significant upregulation of mRNA expression for interleukin-1β (il-1β) and tumor necrosis factor-α (tnf-α) was also observed in fish treated with antigens combined with ISA763A, which peaked at 3 months PSV. In fish treated with antigens combined with AS-F, il-1β and tnf-α expression peaked at 14 days post-primary vaccination (PPV). Phagocytic activity and index increased significantly in the two vaccinated groups. Furthermore, fish in the two vaccinated groups exhibited significantly elevated agglutination titers compared to fish in the control group, in which almost no agglutination reaction was detected. In the efficacy test, the vaccinated and control groupers were treated with S. iniae at 1, 3, and 6 months PSV. The relative percentage survival (RPS) values of antigens with AS-F and antigens with ISA763A were both 100% at 1 and 3 months PSV; at 6 months PSV, the RPS values for these groups were 100% and 97.7%, respectively. Furthermore, the level of protection observed in the field trial closely resembled that achieved on a laboratory scale. Therefore, the proposed vaccine mixed with AS-F or ISA763A improved immune responses and provided safe and long-lasting protection in farmed groupers. |
|---|---|
| AbstractList | Vaccination is the most effective means of preventing infectious diseases; however, few vaccines are effective against Streptococcus iniae (S. iniae) in grouper. This work presents an efficacious and safe vaccine against S. iniae infections in the grouper Epinephelus coioides. The vaccine candidate was the S. iniae GSI-310 strain. The vaccination was administered by intraperitoneal injection, and consisted of formalin-inactivated antigens combined with an AS-F or ISA763A adjuvant. Peripheral blood samples were collected for RT-qPCR and phagocytosis and agglutination assays. Our results indicated that immunoglobulin M (igm) was maximally expressed in the two vaccinated groups at 3 months post-secondary vaccination (PSV). A significant upregulation of mRNA expression for interleukin-1β (il-1β) and tumor necrosis factor-α (tnf-α) was also observed in fish treated with antigens combined with ISA763A, which peaked at 3 months PSV. In fish treated with antigens combined with AS-F, il-1β and tnf-α expression peaked at 14 days post-primary vaccination (PPV). Phagocytic activity and index increased significantly in the two vaccinated groups. Furthermore, fish in the two vaccinated groups exhibited significantly elevated agglutination titers compared to fish in the control group, in which almost no agglutination reaction was detected. In the efficacy test, the vaccinated and control groupers were treated with S. iniae at 1, 3, and 6 months PSV. The relative percentage survival (RPS) values of antigens with AS-F and antigens with ISA763A were both 100% at 1 and 3 months PSV; at 6 months PSV, the RPS values for these groups were 100% and 97.7%, respectively. Furthermore, the level of protection observed in the field trial closely resembled that achieved on a laboratory scale. Therefore, the proposed vaccine mixed with AS-F or ISA763A improved immune responses and provided safe and long-lasting protection in farmed groupers. Vaccination is the most effective means of preventing infectious diseases; however, few vaccines are effective against Streptococcus iniae (S. iniae) in grouper. This work presents an efficacious and safe vaccine against S. iniae infections in the grouper Epinephelus coioides. The vaccine candidate was the S. iniae GSI-310 strain. The vaccination was administered by intraperitoneal injection, and consisted of formalin-inactivated antigens combined with an AS-F or ISA763A adjuvant. Peripheral blood samples were collected for RT-qPCR and phagocytosis and agglutination assays. Our results indicated that immunoglobulin M (igm) was maximally expressed in the two vaccinated groups at 3 months post-secondary vaccination (PSV). A significant upregulation of mRNA expression for interleukin-1 beta (il-1 beta ) and tumor necrosis factor- alpha (tnf- alpha ) was also observed in fish treated with antigens combined with ISA763A, which peaked at 3 months PSV. In fish treated with antigens combined with AS-F, il-1 beta and tnf- alpha expression peaked at 14 days post-primary vaccination (PPV). Phagocytic activity and index increased significantly in the two vaccinated groups. Furthermore, fish in the two vaccinated groups exhibited significantly elevated agglutination titers compared to fish in the control group, in which almost no agglutination reaction was detected. In the efficacy test, the vaccinated and control groupers were treated with S. iniae at 1, 3, and 6 months PSV. The relative percentage survival (RPS) values of antigens with AS-F and antigens with ISA763A were both 100% at 1 and 3 months PSV; at 6 months PSV, the RPS values for these groups were 100% and 97.7%, respectively. Furthermore, the level of protection observed in the field trial closely resembled that achieved on a laboratory scale. Therefore, the proposed vaccine mixed with AS-F or ISA763A improved immune responses and provided safe and long-lasting protection in farmed groupers. Highlights • Proposed vaccine induces the upregulation of immune-related genes. • Vaccinated fish showed significant increase of phagocytic activity. • Groupers vaccinated using the tested vaccine had increased serum agglutination titers. • Proposed vaccine provides protective efficacy against S. iniae. • Proposed vaccine provides safe and long-lasting protection in farmed groupers. •Proposed vaccine induces the upregulation of immune-related genes.•Vaccinated fish showed significant increase of phagocytic activity.•Groupers vaccinated using the tested vaccine had increased serum agglutination titers.•Proposed vaccine provides protective efficacy against S. iniae.•Proposed vaccine provides safe and long-lasting protection in farmed groupers. Vaccination is the most effective means of preventing infectious diseases; however, few vaccines are effective against Streptococcus iniae (S. iniae) in grouper. This work presents an efficacious and safe vaccine against S. iniae infections in the grouper Epinephelus coioides. The vaccine candidate was the S. iniae GSI-310 strain. The vaccination was administered by intraperitoneal injection, and consisted of formalin-inactivated antigens combined with an AS-F or ISA763A adjuvant. Peripheral blood samples were collected for RT-qPCR and phagocytosis and agglutination assays. Our results indicated that immunoglobulin M (igm) was maximally expressed in the two vaccinated groups at 3 months post-secondary vaccination (PSV). A significant upregulation of mRNA expression for interleukin-1β (il-1β) and tumor necrosis factor-α (tnf-α) was also observed in fish treated with antigens combined with ISA763A, which peaked at 3 months PSV. In fish treated with antigens combined with AS-F, il-1β and tnf-α expression peaked at 14 days post-primary vaccination (PPV). Phagocytic activity and index increased significantly in the two vaccinated groups. Furthermore, fish in the two vaccinated groups exhibited significantly elevated agglutination titers compared to fish in the control group, in which almost no agglutination reaction was detected. In the efficacy test, the vaccinated and control groupers were treated with S. iniae at 1, 3, and 6 months PSV. The relative percentage survival (RPS) values of antigens with AS-F and antigens with ISA763A were both 100% at 1 and 3 months PSV; at 6 months PSV, the RPS values for these groups were 100% and 97.7%, respectively. Furthermore, the level of protection observed in the field trial closely resembled that achieved on a laboratory scale. Therefore, the proposed vaccine mixed with AS-F or ISA763A improved immune responses and provided safe and long-lasting protection in farmed groupers. Vaccination is the most effective means of preventing infectious diseases; however, few vaccines are effective against Streptococcus iniae (S. iniae) in grouper. This work presents an efficacious and safe vaccine against S. iniae infections in the grouper Epinephelus coioides. The vaccine candidate was the S. iniae GSI-310 strain. The vaccination was administered by intraperitoneal injection, and consisted of formalin-inactivated antigens combined with an AS-F or ISA763A adjuvant. Peripheral blood samples were collected for RT-qPCR and phagocytosis and agglutination assays. Our results indicated that immunoglobulin M (igm) was maximally expressed in the two vaccinated groups at 3 months post-secondary vaccination (PSV). A significant upregulation of mRNA expression for interleukin-1β (il-1β) and tumor necrosis factor-α (tnf-α) was also observed in fish treated with antigens combined with ISA763A, which peaked at 3 months PSV. In fish treated with antigens combined with AS-F, il-1β and tnf-α expression peaked at 14 days post-primary vaccination (PPV). Phagocytic activity and index increased significantly in the two vaccinated groups. Furthermore, fish in the two vaccinated groups exhibited significantly elevated agglutination titers compared to fish in the control group, in which almost no agglutination reaction was detected. In the efficacy test, the vaccinated and control groupers were treated with S. iniae at 1, 3, and 6 months PSV. The relative percentage survival (RPS) values of antigens with AS-F and antigens with ISA763A were both 100% at 1 and 3 months PSV; at 6 months PSV, the RPS values for these groups were 100% and 97.7%, respectively. Furthermore, the level of protection observed in the field trial closely resembled that achieved on a laboratory scale. Therefore, the proposed vaccine mixed with AS-F or ISA763A improved immune responses and provided safe and long-lasting protection in farmed groupers.Vaccination is the most effective means of preventing infectious diseases; however, few vaccines are effective against Streptococcus iniae (S. iniae) in grouper. This work presents an efficacious and safe vaccine against S. iniae infections in the grouper Epinephelus coioides. The vaccine candidate was the S. iniae GSI-310 strain. The vaccination was administered by intraperitoneal injection, and consisted of formalin-inactivated antigens combined with an AS-F or ISA763A adjuvant. Peripheral blood samples were collected for RT-qPCR and phagocytosis and agglutination assays. Our results indicated that immunoglobulin M (igm) was maximally expressed in the two vaccinated groups at 3 months post-secondary vaccination (PSV). A significant upregulation of mRNA expression for interleukin-1β (il-1β) and tumor necrosis factor-α (tnf-α) was also observed in fish treated with antigens combined with ISA763A, which peaked at 3 months PSV. In fish treated with antigens combined with AS-F, il-1β and tnf-α expression peaked at 14 days post-primary vaccination (PPV). Phagocytic activity and index increased significantly in the two vaccinated groups. Furthermore, fish in the two vaccinated groups exhibited significantly elevated agglutination titers compared to fish in the control group, in which almost no agglutination reaction was detected. In the efficacy test, the vaccinated and control groupers were treated with S. iniae at 1, 3, and 6 months PSV. The relative percentage survival (RPS) values of antigens with AS-F and antigens with ISA763A were both 100% at 1 and 3 months PSV; at 6 months PSV, the RPS values for these groups were 100% and 97.7%, respectively. Furthermore, the level of protection observed in the field trial closely resembled that achieved on a laboratory scale. Therefore, the proposed vaccine mixed with AS-F or ISA763A improved immune responses and provided safe and long-lasting protection in farmed groupers. |
| Author | Liang, Hong-Jen Chen, Yan-Chun Yeh, Shih-Chun Wang, Pei-Chi Chen, Shih-Chu Huang, Hsing-Yen Tsai, Ming-An |
| Author_xml | – sequence: 1 givenname: Hsing-Yen surname: Huang fullname: Huang, Hsing-Yen organization: Department of Veterinary Medicine, National Pingtung University of Science and Technology, Pingtung, Taiwan, ROC – sequence: 2 givenname: Yan-Chun surname: Chen fullname: Chen, Yan-Chun organization: Department of Veterinary Medicine, National Pingtung University of Science and Technology, Pingtung, Taiwan, ROC – sequence: 3 givenname: Pei-Chi surname: Wang fullname: Wang, Pei-Chi organization: Department of Veterinary Medicine, National Pingtung University of Science and Technology, Pingtung, Taiwan, ROC – sequence: 4 givenname: Ming-An surname: Tsai fullname: Tsai, Ming-An organization: Department of Veterinary Medicine, National Pingtung University of Science and Technology, Pingtung, Taiwan, ROC – sequence: 5 givenname: Shih-Chun surname: Yeh fullname: Yeh, Shih-Chun organization: Department of Veterinary Medicine, National Pingtung University of Science and Technology, Pingtung, Taiwan, ROC – sequence: 6 givenname: Hong-Jen surname: Liang fullname: Liang, Hong-Jen organization: Department of Food Science, Yuanpei University, HsinChu, Taiwan, ROC – sequence: 7 givenname: Shih-Chu surname: Chen fullname: Chen, Shih-Chu email: scchen@mail.npust.edu.tw organization: Department of Veterinary Medicine, National Pingtung University of Science and Technology, Pingtung, Taiwan, ROC |
| BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=29054373$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/25192808$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNkl-L1DAUxYusuLOrH0HJi-BLx5u0aVNEQZbxDyz4sAq-hTRNdjO2SU3agfGr-GW9dWYRBBlf2kJ-59z03HORnfngTZY9pbCmQKuX2_VOae28WTOg5RrEGormQbaioi5yxqk4y1bAqjIvKXw9zy5S2gIAL2jzKDvH84YJEKvs58Zap5Xek2CJIjbEQfXO584rPbmdmkxHjoOIulXOp4ncTNGMU9BB6zkR550y-LQGBcHjF5nuDLEqDqi9jWEeTSSbER3GO9OjQgcXXGcSafdIT1Eh4Cb8PdUTNwyzdz_UYvU4e2hVn8yT4_sy-_Ju8_nqQ3796f3Hq7fXua44TLkou0o3toW247yqLDe8qKE2ShcguCq0xoQs7VhraMNbVouqFi1nnRICw6HFZfbi4DvG8H02aZKDS9r0vfImzElSUVYFZawpT6NVwYFRzv_DtWJNUzGAxfXZEZ1bDE2O0Q0q7uX9mhB4fgRU0qq3UXnt0h-uAV4WdYHcqwOnY0gpGiu1m35niSm7XlKQS3nkVh53KpfySBASy4Nq_pf6fsAp3ZuDzuCSds5EqbFC2Kr-m9mbtA1z9Lg_SWViEuTNUsullbQEiiksUb3-t4HsgjtxgV_asPdt |
| CODEN | VACCDE |
| CitedBy_id | crossref_primary_10_3390_vaccines11101555 crossref_primary_10_1016_j_fsi_2017_06_025 crossref_primary_10_1016_j_fsi_2019_11_050 crossref_primary_10_1016_j_aquaculture_2021_737854 crossref_primary_10_1016_j_fsi_2016_04_133 crossref_primary_10_1016_j_aquaculture_2018_03_057 crossref_primary_10_1016_j_fsi_2023_109226 crossref_primary_10_1016_j_fsi_2020_03_029 crossref_primary_10_1007_s11259_023_10081_6 crossref_primary_10_1016_j_fsi_2018_04_041 crossref_primary_10_1016_j_fsi_2019_02_059 crossref_primary_10_3390_vaccines11010009 crossref_primary_10_1016_j_fsi_2024_109572 crossref_primary_10_1007_s10499_020_00554_9 crossref_primary_10_1016_j_fsi_2017_07_018 crossref_primary_10_1080_23144599_2024_2348408 crossref_primary_10_3390_vaccines4040048 crossref_primary_10_1016_j_aquaculture_2018_05_034 crossref_primary_10_14202_vetworld_2019_1806_1815 crossref_primary_10_1111_jfd_13260 crossref_primary_10_1016_j_aquaculture_2025_742174 crossref_primary_10_1016_j_fsi_2017_04_008 crossref_primary_10_1093_nutrit_nuae121 crossref_primary_10_1016_j_fsi_2025_110234 crossref_primary_10_1016_j_jnim_2017_07_002 crossref_primary_10_1016_j_fsi_2021_04_024 crossref_primary_10_1016_j_fsi_2017_06_014 crossref_primary_10_1111_are_14990 crossref_primary_10_7717_peerj_16419 crossref_primary_10_1111_jfd_14009 crossref_primary_10_30910_turkjans_843023 crossref_primary_10_3389_fimmu_2022_1040336 crossref_primary_10_3390_vaccines11020351 crossref_primary_10_1016_j_fsi_2019_12_069 crossref_primary_10_1016_j_aquaculture_2021_736654 crossref_primary_10_1016_j_fsi_2022_108489 crossref_primary_10_1016_j_watbs_2022_100032 crossref_primary_10_1016_j_fsi_2020_01_015 crossref_primary_10_1111_jfd_12828 crossref_primary_10_1016_j_aaf_2018_01_003 crossref_primary_10_3390_vaccines9020086 crossref_primary_10_1071_MA16040 crossref_primary_10_1016_j_fsi_2019_12_021 crossref_primary_10_1152_physiolgenomics_00055_2023 crossref_primary_10_1016_j_fsi_2018_03_060 crossref_primary_10_1002_aah_10045 crossref_primary_10_1016_j_fsi_2019_07_063 |
| Cites_doi | 10.1007/BF01571054 10.1016/j.fsi.2010.12.011 10.1016/j.fsi.2008.12.006 10.1016/j.fsi.2013.02.029 10.1016/S0167-5699(99)01542-X 10.1016/j.fsi.2012.12.011 10.1016/j.dci.2012.06.013 10.1016/j.fsi.2007.10.014 10.1016/S0044-8486(97)00044-6 10.3354/dao061067 10.1006/fsim.1996.0034 10.1371/journal.pone.0040841 10.1128/AEM.64.10.4065-4067.1998 10.1016/S0165-2427(96)05738-8 10.2323/jgam.59.437 10.1016/S1359-6101(02)00028-X 10.1128/IAI.70.8.4591-4599.2002 10.1016/j.fsi.2010.08.018 10.1172/JCI200317592 10.1016/j.vaccine.2009.11.083 10.1099/00207713-26-4-545 10.3354/dao037121 10.1016/S1286-4579(00)01359-9 10.1016/j.vaccine.2004.03.012 10.1016/S0264-410X(96)00150-8 10.1016/j.aquaculture.2005.05.027 10.1006/fsim.2000.0266 10.1006/fsim.1993.1030 10.1016/S0044-8486(00)00346-X 10.3354/dao062177 10.1016/j.fsi.2007.06.005 10.1016/0165-2427(92)90177-R |
| ContentType | Journal Article |
| Copyright | 2014 Elsevier Ltd Elsevier Ltd 2015 INIST-CNRS Copyright © 2014 Elsevier Ltd. All rights reserved. |
| Copyright_xml | – notice: 2014 Elsevier Ltd – notice: Elsevier Ltd – notice: 2015 INIST-CNRS – notice: Copyright © 2014 Elsevier Ltd. All rights reserved. |
| DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7X8 7QL 7T5 7TN C1K F1W H94 H95 L.G 7S9 L.6 |
| DOI | 10.1016/j.vaccine.2014.08.039 |
| DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic Bacteriology Abstracts (Microbiology B) Immunology Abstracts Oceanic Abstracts Environmental Sciences and Pollution Management ASFA: Aquatic Sciences and Fisheries Abstracts AIDS and Cancer Research Abstracts Aquatic Science & Fisheries Abstracts (ASFA) 1: Biological Sciences & Living Resources Aquatic Science & Fisheries Abstracts (ASFA) Professional AGRICOLA AGRICOLA - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic Aquatic Science & Fisheries Abstracts (ASFA) Professional Oceanic Abstracts Bacteriology Abstracts (Microbiology B) ASFA: Aquatic Sciences and Fisheries Abstracts AIDS and Cancer Research Abstracts Immunology Abstracts Aquatic Science & Fisheries Abstracts (ASFA) 1: Biological Sciences & Living Resources Environmental Sciences and Pollution Management AGRICOLA AGRICOLA - Academic |
| DatabaseTitleList | AGRICOLA Aquatic Science & Fisheries Abstracts (ASFA) Professional MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Veterinary Medicine Biology Pharmacy, Therapeutics, & Pharmacology |
| EISSN | 1873-2518 |
| EndPage | 7020 |
| ExternalDocumentID | 25192808 29054373 10_1016_j_vaccine_2014_08_039 1_s2_0_S0264410X14011621 S0264410X14011621 |
| Genre | Research Support, Non-U.S. Gov't Journal Article |
| GroupedDBID | --- --K --M .1- .FO .~1 0R~ 123 1B1 1P~ 1RT 1~. 1~5 4.4 457 4G. 53G 5RE 5VS 7-5 71M 7RV 7X7 88E 8AO 8C1 8FE 8FH 8FI 8FJ 8G5 8P~ 9JM AAAJQ AABNK AAEDT AAEDW AAHBH AAIKJ AAKOC AALRI AAOAW AAQFI AARKO AATTM AAXKI AAXUO AAYWO ABBQC ABFNM ABFRF ABJNI ABKYH ABMAC ABMZM ABRWV ABUWG ABXDB ACDAQ ACGFO ACGFS ACIEU ACIUM ACPRK ACRLP ACVFH ADBBV ADCNI ADEZE ADFRT AEBSH AEFWE AEIPS AEKER AENEX AEUPX AEUYN AEVXI AEXOQ AFKRA AFPUW AFRAH AFRHN AFTJW AFXIZ AGCQF AGEKW AGGSO AGUBO AGYEJ AHMBA AIEXJ AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX AQUVI AXJTR AZQEC BBNVY BENPR BHPHI BKEYQ BKNYI BKOJK BLXMC BNPGV BPHCQ BVXVI CCPQU CJTIS CNWQP CS3 DWQXO EBS EFJIC EFKBS EJD EO8 EO9 EP2 EP3 F5P FDB FIRID FNPLU FYGXN FYUFA G-Q GBLVA GNUQQ GUQSH HCIFZ HMCUK IHE J1W K9- KOM L7B LK8 LUGTX LW9 M0R M0T M1P M29 M2O M41 M7P MO0 N9A NAPCQ O-L O9- O9~ OAUVE OK0 OZT P-8 P-9 P2P PC. PHGZM PHGZT PJZUB PPXIY PQGLB PQQKQ PROAC PSQYO PUEGO Q38 ROL RPZ SAB SCC SDF SDG SDP SES SNL SPCBC SSH SSI SSZ T5K UKHRP UV1 WH7 WOW Z5R ~G- .GJ 29Q 3V. AACTN AAQXK ABWVN ACRPL ADMUD ADNMO ADVLN AFCTW AFJKZ AFKWA AGHFR AHHHB AJOXV ALIPV AMFUW ASPBG AVWKF AZFZN FEDTE FGOYB G-2 HEJ HLV HMG HMK HMO HVGLF HX~ HZ~ R2- RIG SAE SEW SIN SVS WUQ XPP ZGI ZXP AAYXX ACMHX ADSLC AGQPQ AGRNS AGWPP AIGII APXCP CITATION IQODW CGR CUY CVF ECM EIF NPM 7X8 EFLBG 7QL 7T5 7TN C1K F1W H94 H95 L.G 7S9 L.6 |
| ID | FETCH-LOGICAL-c650t-84d6c9fb0bd5566f5e53707eac3085a3cc201f1d2be195b278678b52da8841013 |
| ISSN | 0264-410X 1873-2518 |
| IngestDate | Thu Sep 04 18:24:20 EDT 2025 Fri Sep 05 13:17:58 EDT 2025 Fri Sep 05 12:55:40 EDT 2025 Mon Jul 21 05:40:59 EDT 2025 Wed Apr 02 07:18:30 EDT 2025 Tue Jul 01 03:38:10 EDT 2025 Thu Apr 24 23:11:13 EDT 2025 Sun Feb 23 10:19:19 EST 2025 Tue Aug 26 16:33:24 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 51 |
| Keywords | Grouper Formalin-inactivated vaccine S. iniae Phagocytosis Immune-related genes Field study Immunization Vaccine Streptococcaceae Streptococcus Gene Efficiency Bacteria Micrococcales Inactivated strain |
| Language | English |
| License | CC BY 4.0 Copyright © 2014 Elsevier Ltd. All rights reserved. |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c650t-84d6c9fb0bd5566f5e53707eac3085a3cc201f1d2be195b278678b52da8841013 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| PMID | 25192808 |
| PQID | 1629962004 |
| PQPubID | 23479 |
| PageCount | 7 |
| ParticipantIDs | proquest_miscellaneous_1846312294 proquest_miscellaneous_1635021551 proquest_miscellaneous_1629962004 pubmed_primary_25192808 pascalfrancis_primary_29054373 crossref_citationtrail_10_1016_j_vaccine_2014_08_039 crossref_primary_10_1016_j_vaccine_2014_08_039 elsevier_clinicalkeyesjournals_1_s2_0_S0264410X14011621 elsevier_clinicalkey_doi_10_1016_j_vaccine_2014_08_039 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2014-12-05 |
| PublicationDateYYYYMMDD | 2014-12-05 |
| PublicationDate_xml | – month: 12 year: 2014 text: 2014-12-05 day: 05 |
| PublicationDecade | 2010 |
| PublicationPlace | Kidlington |
| PublicationPlace_xml | – name: Kidlington – name: Netherlands |
| PublicationTitle | Vaccine |
| PublicationTitleAlternate | Vaccine |
| PublicationYear | 2014 |
| Publisher | Elsevier Ltd Elsevier |
| Publisher_xml | – name: Elsevier Ltd – name: Elsevier |
| References | Hamaguchi, Kusuda (bib0060) 1989; 11 Reddy, Corley (bib0090) 1999; 20 Whyte (bib0100) 2007; 23 Dan, Zhang, Li, Li (bib0120) 2013; 34 Zlotkin, Hershko, Eldar (bib0110) 1998; 64 Austin, Austin (bib0010) 2008 Ooyama, Kera, Okada, Inglis, Yoshida (bib0195) 1999; 37 Cunha, Assreuy, Moss, Rees, Leal, Moncad (bib0165) 1994; 81 Lawrence, Saul, Giddy, Kemp, Pye (bib0080) 1997; 15 Gravningen, Sakai, Mishiba, Fujimoto (bib0065) 2008; 24 Sano, Hsu, Apgar, Yu, Sharma, Kuwabara (bib0130) 2003; 112 Low, Liu, Fuller, McGeer (bib0015) 1999; 3 Cui, Zhang, Yao, Zhang, Zhang, Wang (bib0115) 2010; 29 Midtlyng, Reitan, Speilberg (bib0150) 1996; 6 Kisich, Higgins, Diamond, Heifets (bib0170) 2002; 70 Kawakami, Shinohara, Fukuda, Yamashita, Kihara, Sakai (bib0055) 1997; 154 Eldar, Horovitz, Bercovier (bib0140) 1997; 56 Kadowaki, Harada, Sawad, Kohchi, Soma, Takahashi (bib0190) 2009; 27 Kvitt, Colorni (bib0030) 2004; 61 Ninomiya, Murakoa, Kawai, Kusuda (bib0050) 1993; 3 Bridle, Koop, Nowak (bib0180) 2012; 7 Chang, Chen, Su, Liao (bib0135) 2010; 10 Bird, Zou, Wang, Munday, Cunningham, Secombes (bib0160) 2002; 13 Evensen, Brudeseth, Mutoloki (bib0075) 2005; 121 Lam, Wu, Lin, Lin, Chen, Wang (bib0185) 2011; 30 Arthur, Ogawa (bib0040) 1996 Eldar, Bejerano, Bercovier (bib0020) 1994; 28 Jiao, Cheng, Hu, Sun (bib0155) 2010; 28 Lahav, Eyngor, Hurvitz, Ghittino, Lublin, Eldar (bib0025) 2004; 62 Tafalla, Bogwald, Dalmo (bib0045) 2013; 35 Ravelo, Magarinos, Herrero, Costa, Toranzo, Romalde (bib0085) 2006; 251 Chen, Lin, Foung, Han-You Lin (bib0125) 2012; 38 Pier, Madin (bib0005) 1976; 26 Tsai, Wang, Cao, Liao, Liaw, Chen (bib0105) 2013; 59 Ma (bib0175) 2001; 3 Evans, Klesius, Shoemaker (bib0145) 2004; 22 Shoemaker, Evans, Klesius (bib0035) 2000; 188 Anderson, Jeney (bib0070) 1992; 34 Klimovich, Samoilovich, Klimovich (bib0095) 2008; 44 Shoemaker (10.1016/j.vaccine.2014.08.039_bib0035) 2000; 188 Austin (10.1016/j.vaccine.2014.08.039_bib0010) 2008 Arthur (10.1016/j.vaccine.2014.08.039_bib0040) 1996 Chen (10.1016/j.vaccine.2014.08.039_bib0125) 2012; 38 Lam (10.1016/j.vaccine.2014.08.039_bib0185) 2011; 30 Kvitt (10.1016/j.vaccine.2014.08.039_bib0030) 2004; 61 Ninomiya (10.1016/j.vaccine.2014.08.039_bib0050) 1993; 3 Evans (10.1016/j.vaccine.2014.08.039_bib0145) 2004; 22 Kadowaki (10.1016/j.vaccine.2014.08.039_bib0190) 2009; 27 Reddy (10.1016/j.vaccine.2014.08.039_bib0090) 1999; 20 Eldar (10.1016/j.vaccine.2014.08.039_bib0140) 1997; 56 Lahav (10.1016/j.vaccine.2014.08.039_bib0025) 2004; 62 Kisich (10.1016/j.vaccine.2014.08.039_bib0170) 2002; 70 Tafalla (10.1016/j.vaccine.2014.08.039_bib0045) 2013; 35 Zlotkin (10.1016/j.vaccine.2014.08.039_bib0110) 1998; 64 Evensen (10.1016/j.vaccine.2014.08.039_bib0075) 2005; 121 Lawrence (10.1016/j.vaccine.2014.08.039_bib0080) 1997; 15 Anderson (10.1016/j.vaccine.2014.08.039_bib0070) 1992; 34 Whyte (10.1016/j.vaccine.2014.08.039_bib0100) 2007; 23 Eldar (10.1016/j.vaccine.2014.08.039_bib0020) 1994; 28 Chang (10.1016/j.vaccine.2014.08.039_bib0135) 2010; 10 Jiao (10.1016/j.vaccine.2014.08.039_bib0155) 2010; 28 Ooyama (10.1016/j.vaccine.2014.08.039_bib0195) 1999; 37 Kawakami (10.1016/j.vaccine.2014.08.039_bib0055) 1997; 154 Bridle (10.1016/j.vaccine.2014.08.039_bib0180) 2012; 7 Cui (10.1016/j.vaccine.2014.08.039_bib0115) 2010; 29 Klimovich (10.1016/j.vaccine.2014.08.039_bib0095) 2008; 44 Gravningen (10.1016/j.vaccine.2014.08.039_bib0065) 2008; 24 Sano (10.1016/j.vaccine.2014.08.039_bib0130) 2003; 112 Midtlyng (10.1016/j.vaccine.2014.08.039_bib0150) 1996; 6 Bird (10.1016/j.vaccine.2014.08.039_bib0160) 2002; 13 Pier (10.1016/j.vaccine.2014.08.039_bib0005) 1976; 26 Hamaguchi (10.1016/j.vaccine.2014.08.039_bib0060) 1989; 11 Low (10.1016/j.vaccine.2014.08.039_bib0015) 1999; 3 Ravelo (10.1016/j.vaccine.2014.08.039_bib0085) 2006; 251 Cunha (10.1016/j.vaccine.2014.08.039_bib0165) 1994; 81 Dan (10.1016/j.vaccine.2014.08.039_bib0120) 2013; 34 Ma (10.1016/j.vaccine.2014.08.039_bib0175) 2001; 3 Tsai (10.1016/j.vaccine.2014.08.039_bib0105) 2013; 59 |
| References_xml | – volume: 23 start-page: 1127 year: 2007 end-page: 1151 ident: bib0100 article-title: The innate immune response of finfish – a review of current knowledge publication-title: Fish Shellfish Immunol – volume: 64 start-page: 4065 year: 1998 end-page: 4067 ident: bib0110 article-title: Possible transmission of publication-title: Appl Environ Microbiol – start-page: 18 year: 2008 ident: bib0010 article-title: Characteristics of the diseases. Bacterial fish pathogens: disease of farmed and wild fish – volume: 121 start-page: 117 year: 2005 end-page: 125 ident: bib0075 article-title: The vaccine formulation and its role in inflammatory processes in fish-effects and adverse effects publication-title: Dev Biol (Basel) – volume: 28 start-page: 1832 year: 2010 end-page: 1837 ident: bib0155 article-title: Comparative study of the effects of aluminum adjuvants and Freund's incomplete adjuvant on the immune response to an publication-title: Vaccine – volume: 3 start-page: 53 year: 1999 end-page: 65 ident: bib0015 article-title: : an emerging pathogen in the aquaculture industry publication-title: Emerging infections – volume: 7 start-page: e40841 year: 2012 ident: bib0180 article-title: Identification of surrogates of protection against yersiniosis in immersion vaccinated Atlantic salmon publication-title: PLoS ONE – volume: 29 start-page: 1060 year: 2010 end-page: 1065 ident: bib0115 article-title: Immunoglobulin M gene expression analysis of orange-spotted grouper, publication-title: Fish Shellfish Immunol – volume: 81 start-page: 211 year: 1994 end-page: 215 ident: bib0165 article-title: Differential induction of nitric oxide synthase in various organs of the mouse during endotoxaemia: role of TNF-alpha and IL-1-beta publication-title: Immunology – volume: 70 start-page: 4591 year: 2002 end-page: 4599 ident: bib0170 article-title: Tumor necrosis factor alpha stimulates killing of publication-title: Infect Immun – volume: 28 start-page: 139 year: 1994 end-page: 143 ident: bib0020 article-title: and publication-title: Curr Microbiol – volume: 34 start-page: 379 year: 1992 end-page: 389 ident: bib0070 article-title: Immunostimulants added to injected publication-title: Vet Immunol Immunopathol – volume: 37 start-page: 121 year: 1999 end-page: 126 ident: bib0195 article-title: The protective immune response of yellowtail publication-title: Dis Aquat Organ – volume: 6 start-page: 335 year: 1996 end-page: 350 ident: bib0150 article-title: Experimental studies on the efficacy and side-effects of intraperitoneal vaccination of Atlantic salmon ( publication-title: Fish Shellfish Immunol – volume: 13 start-page: 483 year: 2002 end-page: 502 ident: bib0160 article-title: Evolution of interleukin-1β publication-title: Cytokine Growth Factor Rev – volume: 112 start-page: 389 year: 2003 end-page: 397 ident: bib0130 article-title: Critical role of galectin-3 in phagocytosis by macrophages publication-title: J Clin Invest – volume: 27 start-page: 585 year: 2009 end-page: 594 ident: bib0190 article-title: Two types of tumor necrosis factor-a in bluefin tuna ( publication-title: Fish Shellfish Immunol – volume: 61 start-page: 67 year: 2004 end-page: 73 ident: bib0030 article-title: Strain variation and geographic endemism in publication-title: Dis Aquat Organ – volume: 59 start-page: 437 year: 2013 end-page: 449 ident: bib0105 article-title: Immunoprotection of glyceraldehydes-3-phosphate dehydrogenase (GAPDH) from publication-title: J Gen Appl Microbiol – volume: 251 start-page: 153 year: 2006 end-page: 158 ident: bib0085 article-title: Use of adjuvanted vaccines to lengthen the protection against lactococcosis in rainbow trout ( publication-title: Aquaculture – volume: 34 start-page: 885 year: 2013 end-page: 891 ident: bib0120 article-title: Immune responses and immune-related gene expression profile in orange-spotted grouper after immunization with publication-title: Fish Shellfish Immunol – volume: 188 start-page: 229 year: 2000 end-page: 235 ident: bib0035 article-title: Density and dose: factors affecting mortality of publication-title: Aquaculture – volume: 15 start-page: 176 year: 1997 end-page: 178 ident: bib0080 article-title: Phase I trial in humans of an oil-based adjuvant SEPPIC MONTANIDE ISA 720 publication-title: Vaccine – volume: 38 start-page: 285 year: 2012 end-page: 294 ident: bib0125 article-title: The bioactivity of teleost IL-6: IL-6 protein in orange-spotted grouper ( publication-title: Dev Comp Immunol – volume: 44 start-page: 131 year: 2008 end-page: 143 ident: bib0095 article-title: Problem of J-chain of immunoglobulins publication-title: Zh Evol Biokhim Fiziol – volume: 154 start-page: 95 year: 1997 end-page: 105 ident: bib0055 article-title: The efficacy of lipopolysaccharide mixed chloroform-killed cell (LPS-CKC) bacterin of publication-title: Aquaculture – volume: 11 start-page: 11 year: 1989 end-page: 16 ident: bib0060 article-title: Field testing of publication-title: Bull Mar Sci Fish Kochi Univ – volume: 26 start-page: 545 year: 1976 end-page: 553 ident: bib0005 article-title: sp. nov., a beta hemolytic streptococcus isolated from an Amazon freshwater dolphin, publication-title: Int J Syst Bacteriol – volume: 10 start-page: 505 year: 2010 end-page: 514 ident: bib0135 article-title: Immunomodulation by dietary β-1, 3-glucan in the brooders of the black tiger shrimp publication-title: Fish Shellfish Immunol – volume: 62 start-page: 177 year: 2004 end-page: 180 ident: bib0025 article-title: type II infections in rainbow trout publication-title: Dis Aquat Organ – volume: 3 start-page: 313 year: 1993 end-page: 314 ident: bib0050 article-title: Duration of resistance of yellowtail against pseudotuberculosis induced by publication-title: Fish Shellfish Immunol – volume: 35 start-page: 1740 year: 2013 end-page: 1750 ident: bib0045 article-title: Adjuvants and immunostimulants in fish vaccines: current knowledge and future perspectives publication-title: Fish Shellfish Immunol – volume: 24 start-page: 523 year: 2008 end-page: 529 ident: bib0065 article-title: The efficacy and safety of an oil-based vaccine against publication-title: Fish Shellfish Immunol – volume: 22 start-page: 3769 year: 2004 end-page: 3773 ident: bib0145 article-title: Efficacy of publication-title: Vaccine – volume: 56 start-page: 175 year: 1997 end-page: 183 ident: bib0140 article-title: Development of a vaccine against publication-title: Vet Immunol Immunopathol – volume: 30 start-page: 618 year: 2011 end-page: 629 ident: bib0185 article-title: The expression of two novel orange-spotted grouper ( publication-title: Fish Shellfish Immunol – volume: 20 start-page: 582 year: 1999 end-page: 588 ident: bib0090 article-title: The contribution of ER quality control to the biologic functions of secretory IgM publication-title: Immunol Today – start-page: 9 year: 1996 end-page: 31 ident: bib0040 article-title: A brief overview of disease problems in the culture of marine finfishes in east and southeast Asia publication-title: Aquaculture health management strategies for marine fishes – volume: 3 start-page: 121 year: 2001 end-page: 129 ident: bib0175 article-title: TNF-alpha and IL-12: a balancing act in macrophage functioning publication-title: Microbes Infect – volume: 28 start-page: 139 year: 1994 ident: 10.1016/j.vaccine.2014.08.039_bib0020 article-title: Streptococcus shiloi and Streptococcus difficile: two new streptococcal species causing a meningoencephalitis in fish publication-title: Curr Microbiol doi: 10.1007/BF01571054 – volume: 30 start-page: 618 year: 2011 ident: 10.1016/j.vaccine.2014.08.039_bib0185 article-title: The expression of two novel orange-spotted grouper (Epinephelus coioides) TNF genes in peripheral blood leukocytes, various organs, and fish larvae publication-title: Fish Shellfish Immunol doi: 10.1016/j.fsi.2010.12.011 – volume: 27 start-page: 585 year: 2009 ident: 10.1016/j.vaccine.2014.08.039_bib0190 article-title: Two types of tumor necrosis factor-a in bluefin tuna (Thunnus orientalis) genes:Molecular cloning and expression profile in response to several immunological stimulants publication-title: Fish Shellfish Immunol doi: 10.1016/j.fsi.2008.12.006 – volume: 35 start-page: 1740 year: 2013 ident: 10.1016/j.vaccine.2014.08.039_bib0045 article-title: Adjuvants and immunostimulants in fish vaccines: current knowledge and future perspectives publication-title: Fish Shellfish Immunol doi: 10.1016/j.fsi.2013.02.029 – volume: 3 start-page: 53 year: 1999 ident: 10.1016/j.vaccine.2014.08.039_bib0015 article-title: Streptococcus iniae: an emerging pathogen in the aquaculture industry – volume: 20 start-page: 582 year: 1999 ident: 10.1016/j.vaccine.2014.08.039_bib0090 article-title: The contribution of ER quality control to the biologic functions of secretory IgM publication-title: Immunol Today doi: 10.1016/S0167-5699(99)01542-X – volume: 34 start-page: 885 year: 2013 ident: 10.1016/j.vaccine.2014.08.039_bib0120 article-title: Immune responses and immune-related gene expression profile in orange-spotted grouper after immunization with Cryptocaryon irritans vaccine publication-title: Fish Shellfish Immunol doi: 10.1016/j.fsi.2012.12.011 – volume: 38 start-page: 285 year: 2012 ident: 10.1016/j.vaccine.2014.08.039_bib0125 article-title: The bioactivity of teleost IL-6: IL-6 protein in orange-spotted grouper (Epinephelus coioides) induces Th2 cell differentiation pathway and antibody production publication-title: Dev Comp Immunol doi: 10.1016/j.dci.2012.06.013 – volume: 24 start-page: 523 year: 2008 ident: 10.1016/j.vaccine.2014.08.039_bib0065 article-title: The efficacy and safety of an oil-based vaccine against Photobacterium damsel subsp. piscicida in yellowtail (Seriola quinqueradiata): a field study publication-title: Fish Shellfish Immunol doi: 10.1016/j.fsi.2007.10.014 – volume: 44 start-page: 131 year: 2008 ident: 10.1016/j.vaccine.2014.08.039_bib0095 article-title: Problem of J-chain of immunoglobulins publication-title: Zh Evol Biokhim Fiziol – volume: 154 start-page: 95 year: 1997 ident: 10.1016/j.vaccine.2014.08.039_bib0055 article-title: The efficacy of lipopolysaccharide mixed chloroform-killed cell (LPS-CKC) bacterin of Pasteurella piscicida on yellowtail, Seriola quinqueradiata publication-title: Aquaculture doi: 10.1016/S0044-8486(97)00044-6 – volume: 61 start-page: 67 year: 2004 ident: 10.1016/j.vaccine.2014.08.039_bib0030 article-title: Strain variation and geographic endemism in Streptococcus iniae publication-title: Dis Aquat Organ doi: 10.3354/dao061067 – volume: 6 start-page: 335 year: 1996 ident: 10.1016/j.vaccine.2014.08.039_bib0150 article-title: Experimental studies on the efficacy and side-effects of intraperitoneal vaccination of Atlantic salmon (Salmo salar L.) against furunculosis publication-title: Fish Shellfish Immunol doi: 10.1006/fsim.1996.0034 – volume: 81 start-page: 211 year: 1994 ident: 10.1016/j.vaccine.2014.08.039_bib0165 article-title: Differential induction of nitric oxide synthase in various organs of the mouse during endotoxaemia: role of TNF-alpha and IL-1-beta publication-title: Immunology – volume: 7 start-page: e40841 year: 2012 ident: 10.1016/j.vaccine.2014.08.039_bib0180 article-title: Identification of surrogates of protection against yersiniosis in immersion vaccinated Atlantic salmon publication-title: PLoS ONE doi: 10.1371/journal.pone.0040841 – volume: 64 start-page: 4065 year: 1998 ident: 10.1016/j.vaccine.2014.08.039_bib0110 article-title: Possible transmission of Streptococcus iniae from wild fish to cultured marine fish publication-title: Appl Environ Microbiol doi: 10.1128/AEM.64.10.4065-4067.1998 – volume: 56 start-page: 175 year: 1997 ident: 10.1016/j.vaccine.2014.08.039_bib0140 article-title: Development of a vaccine against S. iniae infection in farmed rainbow trout publication-title: Vet Immunol Immunopathol doi: 10.1016/S0165-2427(96)05738-8 – volume: 59 start-page: 437 year: 2013 ident: 10.1016/j.vaccine.2014.08.039_bib0105 article-title: Immunoprotection of glyceraldehydes-3-phosphate dehydrogenase (GAPDH) from Lactococcus garviease against Lactococcosis in tilapia publication-title: J Gen Appl Microbiol doi: 10.2323/jgam.59.437 – volume: 13 start-page: 483 year: 2002 ident: 10.1016/j.vaccine.2014.08.039_bib0160 article-title: Evolution of interleukin-1β publication-title: Cytokine Growth Factor Rev doi: 10.1016/S1359-6101(02)00028-X – volume: 70 start-page: 4591 year: 2002 ident: 10.1016/j.vaccine.2014.08.039_bib0170 article-title: Tumor necrosis factor alpha stimulates killing of Mycobacterium tuberculosis by human neutrophils publication-title: Infect Immun doi: 10.1128/IAI.70.8.4591-4599.2002 – volume: 29 start-page: 1060 year: 2010 ident: 10.1016/j.vaccine.2014.08.039_bib0115 article-title: Immunoglobulin M gene expression analysis of orange-spotted grouper, Epinephelus coioides, following heat shock and Vibrio alginolyticus challenge publication-title: Fish Shellfish Immunol doi: 10.1016/j.fsi.2010.08.018 – volume: 112 start-page: 389 year: 2003 ident: 10.1016/j.vaccine.2014.08.039_bib0130 article-title: Critical role of galectin-3 in phagocytosis by macrophages publication-title: J Clin Invest doi: 10.1172/JCI200317592 – volume: 28 start-page: 1832 year: 2010 ident: 10.1016/j.vaccine.2014.08.039_bib0155 article-title: Comparative study of the effects of aluminum adjuvants and Freund's incomplete adjuvant on the immune response to an Edwardsiella tarda major antigen publication-title: Vaccine doi: 10.1016/j.vaccine.2009.11.083 – volume: 26 start-page: 545 year: 1976 ident: 10.1016/j.vaccine.2014.08.039_bib0005 article-title: Streptococcus iniae sp. nov., a beta hemolytic streptococcus isolated from an Amazon freshwater dolphin, Inia geoffrensis publication-title: Int J Syst Bacteriol doi: 10.1099/00207713-26-4-545 – volume: 37 start-page: 121 year: 1999 ident: 10.1016/j.vaccine.2014.08.039_bib0195 article-title: The protective immune response of yellowtail Seriola quinqueradiata to the bacterial fish pathogen Lactococcus garvieae publication-title: Dis Aquat Organ doi: 10.3354/dao037121 – volume: 3 start-page: 121 year: 2001 ident: 10.1016/j.vaccine.2014.08.039_bib0175 article-title: TNF-alpha and IL-12: a balancing act in macrophage functioning publication-title: Microbes Infect doi: 10.1016/S1286-4579(00)01359-9 – start-page: 9 year: 1996 ident: 10.1016/j.vaccine.2014.08.039_bib0040 article-title: A brief overview of disease problems in the culture of marine finfishes in east and southeast Asia – volume: 22 start-page: 3769 year: 2004 ident: 10.1016/j.vaccine.2014.08.039_bib0145 article-title: Efficacy of Streptococcus agalactiae (group B) vaccine in tilapia (Oreochromis niloticus) by intraperitoneal and bath immersion administration publication-title: Vaccine doi: 10.1016/j.vaccine.2004.03.012 – volume: 15 start-page: 176 year: 1997 ident: 10.1016/j.vaccine.2014.08.039_bib0080 article-title: Phase I trial in humans of an oil-based adjuvant SEPPIC MONTANIDE ISA 720 publication-title: Vaccine doi: 10.1016/S0264-410X(96)00150-8 – volume: 251 start-page: 153 year: 2006 ident: 10.1016/j.vaccine.2014.08.039_bib0085 article-title: Use of adjuvanted vaccines to lengthen the protection against lactococcosis in rainbow trout (Oncorhynchus mykiss) publication-title: Aquaculture doi: 10.1016/j.aquaculture.2005.05.027 – volume: 11 start-page: 11 year: 1989 ident: 10.1016/j.vaccine.2014.08.039_bib0060 article-title: Field testing of Pasteurella piscicida fomalin killed-bacterin against pseudotuberculosis in cultured yellowtail publication-title: Bull Mar Sci Fish Kochi Univ – volume: 10 start-page: 505 year: 2010 ident: 10.1016/j.vaccine.2014.08.039_bib0135 article-title: Immunomodulation by dietary β-1, 3-glucan in the brooders of the black tiger shrimp Penaeus monodon publication-title: Fish Shellfish Immunol doi: 10.1006/fsim.2000.0266 – volume: 121 start-page: 117 year: 2005 ident: 10.1016/j.vaccine.2014.08.039_bib0075 article-title: The vaccine formulation and its role in inflammatory processes in fish-effects and adverse effects publication-title: Dev Biol (Basel) – start-page: 18 year: 2008 ident: 10.1016/j.vaccine.2014.08.039_bib0010 – volume: 3 start-page: 313 year: 1993 ident: 10.1016/j.vaccine.2014.08.039_bib0050 article-title: Duration of resistance of yellowtail against pseudotuberculosis induced by Pasteurella piscicida ribosomal and formalin-killed vaccines publication-title: Fish Shellfish Immunol doi: 10.1006/fsim.1993.1030 – volume: 188 start-page: 229 year: 2000 ident: 10.1016/j.vaccine.2014.08.039_bib0035 article-title: Density and dose: factors affecting mortality of Streptococcus iniae infected tilapia (Oreochromis niloticus) publication-title: Aquaculture doi: 10.1016/S0044-8486(00)00346-X – volume: 62 start-page: 177 year: 2004 ident: 10.1016/j.vaccine.2014.08.039_bib0025 article-title: Streptococcus iniae type II infections in rainbow trout Oncorhynchus mykiss publication-title: Dis Aquat Organ doi: 10.3354/dao062177 – volume: 23 start-page: 1127 year: 2007 ident: 10.1016/j.vaccine.2014.08.039_bib0100 article-title: The innate immune response of finfish – a review of current knowledge publication-title: Fish Shellfish Immunol doi: 10.1016/j.fsi.2007.06.005 – volume: 34 start-page: 379 year: 1992 ident: 10.1016/j.vaccine.2014.08.039_bib0070 article-title: Immunostimulants added to injected Aeromonas salmonicida bacterin enhance the defense mechanisms and protection in rainbow trout (Oncorhynchus mykiss) publication-title: Vet Immunol Immunopathol doi: 10.1016/0165-2427(92)90177-R |
| SSID | ssj0005319 |
| Score | 2.3795795 |
| Snippet | •Proposed vaccine induces the upregulation of immune-related genes.•Vaccinated fish showed significant increase of phagocytic activity.•Groupers vaccinated... Highlights • Proposed vaccine induces the upregulation of immune-related genes. • Vaccinated fish showed significant increase of phagocytic activity. •... Vaccination is the most effective means of preventing infectious diseases; however, few vaccines are effective against Streptococcus iniae (S. iniae) in... |
| SourceID | proquest pubmed pascalfrancis crossref elsevier |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 7014 |
| SubjectTerms | adjuvants agglutination Agglutination Tests Allergy and Immunology Animals Antibodies, Bacterial - blood antigens Applied microbiology Bacteriology Bass Biological and medical sciences blood sampling Epinephelus coioides field experimentation Field study Fish Diseases - prevention & control Formalin-inactivated vaccine Fundamental and applied biological sciences. Psychology gene expression Grouper Immune-related genes Immunization - methods immunoglobulin M Immunoglobulin M - blood infectious diseases Injections, Intraperitoneal interleukin-1beta Interleukin-1beta - analysis intraperitoneal injection Leukocytes, Mononuclear - immunology Marine messenger RNA Microbiology Miscellaneous necrosis Phagocytosis quantitative polymerase chain reaction reverse transcriptase polymerase chain reaction S. iniae Streptococcal Infections - prevention & control Streptococcal Infections - veterinary Streptococcal Vaccines - administration & dosage Streptococcal Vaccines - immunology Streptococcus - immunology Streptococcus - isolation & purification Streptococcus iniae Survival Analysis tumor necrosis factor-alpha Tumor Necrosis Factor-alpha - analysis vaccination vaccines Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects) Vaccines, Inactivated - administration & dosage Vaccines, Inactivated - immunology |
| Title | Efficacy of a formalin-inactivated vaccine against Streptococcus iniae infection in the farmed grouper Epinephelus coioides by intraperitoneal immunization |
| URI | https://www.clinicalkey.com/#!/content/1-s2.0-S0264410X14011621 https://www.clinicalkey.es/playcontent/1-s2.0-S0264410X14011621 https://www.ncbi.nlm.nih.gov/pubmed/25192808 https://www.proquest.com/docview/1629962004 https://www.proquest.com/docview/1635021551 https://www.proquest.com/docview/1846312294 |
| Volume | 32 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bT9swFLYYaNOkadq6W3dBnjTxAumci-PkkVWd0CZQtQErT5HjOCMItRVpkeBhf2S_Z_9rx5dcgAIbL1Fk5bhOz2f7HOd85yD0IQho4Eovd6iIwUEJWOBwmTEnFILkNI99qrlV2zvh1l7wZURHS0t_WlFL81naE-cLeSV30Sq0gV4VS_Y_NFt3Cg1wD_qFK2gYrv-k44HK_6DqtWuSozY_wWp0irFiK5xyZUyecqE-na_zn7wAS1B_hZ7OJrAMirkKxSq4rAOy6qDHnJ_AJrmuGR8qCGQKPUwP5TFIiEkxKTJZKrO1UAfDKlOySuitkndorsl5o2tr9O6bMTQIsmfUW-qcwjloyGh9SxU54GOnfziv239YgaEsoL2oTxtKU0t7W3WzOW4fYLg6TSKhrXUObDIncMmovSg3h57zOiWtWWIZMaxTu10zosl0V7cCcypx1LP_s4riC3S2VpM86WLq7UH_q-uUXo8434k2EclIeZ5uaOjbl1Jyu0npJSS58ug9tOIxMOFgWe39akUa-bq-TP2eDZHs48LhXWciPZryEiZubiquXO8SadNo9wl6bH0avGkA-hQtyXEH3TdVTs866MG2jd_ooLWhyZR-toF3G-JfuYHX8LDJoQ4ynX0VpqW54rgSf4Z-V4DHkxxzvAjw2L4ptoDHFwCPNeBxDXi4wwB4bACPLeBxC_C4AjxOz_AlwOM24J-jvc-D3f6WY6uLOAK8kpkTBVko4jwlaUbBp8mppD4jDAwRH9wQ7gsBKsndzEulG9PUYxHYdSn1Mh5FoEXXf4GWx_BrrxCmKU0zkWVMRDxIAx5nPM9TzomQuUt52EVBpdBE2NT7qgLMcVLFWB4l9t9JFA4SVRnWj7uoV4tNTe6Z2wTCCi1JRawGUyCBKXGbIFskKEu72JXJdZDvotULqKwH6sXgDPrM76L3FUwT2LnU50g-lpM5dBmCKRyq9fymZ3yqvBLq3vAMuFC-63kx9PPSzINmFOCgehGJXt_5Bd-gh82i9RYtz07m8h34IbN0Vc9yuLIRg2vUh_uVT4Od4be_OSc7eA |
| linkProvider | Elsevier |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Efficacy+of+a+formalin-inactivated+vaccine+against+Streptococcus+iniae+infection+in+the+farmed+grouper+Epinephelus+coioides+by+intraperitoneal+immunization&rft.jtitle=Vaccine&rft.au=Huang%2C+Hsing-Yen&rft.au=Chen%2C+Yan-Chun&rft.au=Wang%2C+Pei-Chi&rft.au=Tsai%2C+Ming-An&rft.date=2014-12-05&rft.issn=0264-410X&rft.volume=32&rft.issue=51&rft.spage=7014&rft.epage=7020&rft_id=info:doi/10.1016%2Fj.vaccine.2014.08.039&rft.externalDBID=ECK1-s2.0-S0264410X14011621&rft.externalDocID=1_s2_0_S0264410X14011621 |
| thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F0264410X%2FS0264410X14X00526%2Fcov150h.gif |